Elanco Animal Health Incorporated Common Stock vs Sun Life Financial Inc. Common Stock — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.7 (market cap $11.27B), while Sun Life Financial Inc. Common Stock trades at $77.62 (market cap $43.44B). The key difference: Sun Life Financial Inc. Common Stock is far larger — about 3.9× Elanco Animal Health Incorporated Common Stock's market cap, and Sun Life Financial Inc. Common Stock pays a 3.47% dividend while Elanco Animal Health Incorporated Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 6 Days and Sun Life Financial Inc. Common Stock for 0 Days on average.
| ELAN | SLF | |
|---|---|---|
Market Cap | $11.27B | $43.44B |
Volume | 4,942,915 | 333,821 |
Sector | Health | Financials |
52-Week High | $26.84 | $84.07 |
52-Week Low | $19.80 | $57.60 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $14.65B | $45.17B |
Dividend Yield | — | 3.47% |
Signals from Pluang's Aura AI — not financial advice
ELAN trades at $22.41, down 0.66% today, with a bearish technical signal from moving averages. The company reported a net loss of $232 million in 2025, though revenue grew to $4.72 billion. Recent earnings beats and a 71% analyst buy rating reflect optimism around new product launches like Zenrelia and deleveraging plans discussed at recent conferences.
The outlook hinges on execution of growth initiatives to achieve profitability. Upside exists if new products gain market share as projected, but risks include persistent losses, competitive pressures, and high debt. The consensus price target of $28.00 suggests 25% potential upside from current levels.
Sun Life Financial (SLF) trades at $77.87, up 0.69% on the day, reflecting steady momentum. The stock shows consistent earnings beats in recent quarters, with Q3 2026 results pending. Financial health is solid, with a P/E of 18.82 and robust cash flow projections for 2026. Recent strategic moves include expanding disability benefits and forming a reinsurance partnership, signaling growth initiatives.
The outlook for SLF is cautiously optimistic, supported by earnings strength and strategic expansions. Key risks include competitive pressures and macroeconomic volatility. Analyst sentiment is mixed, with a majority hold rating, suggesting potential stability but limited near-term upside. Investors should weigh solid fundamentals against sector headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Sun Life Financial Inc. is a Canada-based financial services company providing insurance, wealth and asset management, and health solutions for individuals and institutions. Its products span life, health, and disability insurance along with mutual funds and pension asset management, through operations in Canada, US, the United Kingdom, Ireland, and across Asia.
Read more on SLF →